First-line treatment of patients with disseminated poorly differentiated neuroendocrine carcinomas with carboplatin, etoposide, and vincristine: A single institution experience

By Olsen Ingrid Holst   Langer Seppo W.   Jepsen Ida   Assens Maria   Federspiel Birgitte   Hasselby Jane Preuss   Hansen Carsten Palnæs   Kjær Andreas   Knigge Ulrich  

Acta Oncologica, Vol. 51, Iss. 1, 2012-01 ,pp. : 97-100

Informa Healthcare

Access to resources Recommend Favorite

Clinical significance of blood chromogranin A measurement in neuroendocrine tumours

By Seregni E.   Ferrari L.   Bajetta E.   Martinetti A.   Bombardieri E.  

Annals of Oncology, Vol. 12, Iss. 2, 2001-02 ,pp. : 69-72

Springer Publishing Company

Access to resources Recommend Favorite

Detection of circulating cells expressing chromogranin A gene transcripts in patients with lung neuroendocrine carcinoma

By Begueret H.   Vergier B.   Begueret J.   Vernejoux J.M.   Jougon J.   Trouette R.   Taytard A.   Velly J.F.   Merlio J.P.   de Mascarel A.  

European Journal of Cancer, Vol. 38, Iss. 17, 2002-11 ,pp. : 2325-2330

Elsevier

Access to resources Recommend Favorite

Clinical-radiological presentation and outcome of surgically treated pulmonary carcinoid tumours: a long-term single institution experience

By Schrevens L.   Vansteenkiste J.   Deneffe G.   De Leyn P.   Verbeken E.   Vandenberghe T.   Demedts M.  

Lung Cancer, Vol. 43, Iss. 1, 2004-01 ,pp. : 39-45

Elsevier

Access to resources Recommend Favorite

Incidence of septicaemias and invasive mycoses in children undergoing treatment for solid tumours - a 12-year experience at a single Italian institution

By Haupt R.   Romanengo M.   Fears T.   Viscoli C.   Castagnola E.  

European Journal of Cancer, Vol. 37, Iss. 18, 2001-12 ,pp. : 2413-2419

Elsevier

Access to resources Recommend Favorite